» Articles » PMID: 39521610

Intraoperative Neurophysiologic Monitoring During Cardiac Surgery: an Observational Cohort Study

Abstract

Objective: To evaluate the impact of intraoperative neuromonitoring (IONM) on stroke and operative mortality after coronary and/or valvular operations.

Methods: This was an observational study of coronary and/or valvular heart operations from 2010 to 2021. Baseline characteristics and postoperative outcomes were compared by the use or non-use of IONM, which included both electroencephalography and somatosensory-evoked potentials. Propensity-score matching was employed to assess the association of IONM usage with operative mortality and stroke.

Results: A total of 19 299 patients underwent a cardiac operation, of which 589 (3.1%) had IONM. Patients with IONM were more likely to have had baseline cerebrovascular disease (60% vs 22%). Patients with IONM had increased operative mortality (5.3% vs 2.5%) and stroke (4.9% vs 1.9%). Moreover, stroke and mortality were highly correlated, with 14% of strokes resulting in death, while only 2% of non-strokes resulted in death (p<0.001). The unadjusted Kaplan-Meier survival estimate was significantly lower among the group with IONM (p<0.001, log-rank). After propensity matching, however, there was no difference in operative mortality or stroke across each group: 3.6% vs 5.3% for mortality and 3.7% vs 5.4% for stroke. In the propensity-matched cohort, the Kaplan-Meier survival estimates were not significantly different across each group (p=0.419, log-rank).

Conclusions: Adjusting for baseline risk, there was no significant difference in adverse outcomes across each group. IONM may serve as a biomarker of cerebral ischaemia, and empirical adjustments based on changes may provide benefits for neurologic outcomes in high-risk patients. The efficacy of IONM during cardiac surgery should be prospectively validated.

References
1.
Paras S, Mina A, Crammond D, Visweswaran S, Anetakis K, Balzer J . Cardiovascular-related mortality after intraoperative neurophysiologic monitoring changes during carotid endarterectomy. Clin Neurophysiol. 2022; 139:43-48. DOI: 10.1016/j.clinph.2022.04.005. View

2.
Grant S, Kendall S, Goodwin A, Cooper G, Trivedi U, Page R . Trends and outcomes for cardiac surgery in the United Kingdom from 2002 to 2016. JTCVS Open. 2022; 7:259-269. PMC: 9390523. DOI: 10.1016/j.xjon.2021.02.001. View

3.
Edmonds Jr H, Rodriguez R, Audenaert S, Austin 3rd E, Pollock Jr S, Ganzel B . The role of neuromonitoring in cardiovascular surgery. J Cardiothorac Vasc Anesth. 1996; 10(1):15-23. DOI: 10.1016/s1053-0770(96)80174-1. View

4.
Hogue Jr C, Murphy S, Schechtman K, Davila-Roman V . Risk factors for early or delayed stroke after cardiac surgery. Circulation. 1999; 100(6):642-7. DOI: 10.1161/01.cir.100.6.642. View

5.
Chang R, Reddy R, Sudadi S, Balzer J, Crammond D, Anetakis K . Diagnostic accuracy of various EEG changes during carotid endarterectomy to detect 30-day perioperative stroke: A systematic review. Clin Neurophysiol. 2020; 131(7):1508-1516. DOI: 10.1016/j.clinph.2020.03.037. View